Updated Jul 16, 2026
FARRELL PETER C has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $5.09M.

Peter C. Farrell is a prominent figure in the medical device industry, known for his role as a director at ResMed Inc., a leading company in respiratory care. He has also been involved with Arcturus Therapeutics Holdings Inc., contributing to advancements in therapeutic technologies.
| Role | Director |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-02 | RMD | RESMED INC | S — Open-market sale [10b5-1] | 2.0K | $225.00 | $450K |
| 2026-03-05 | RMD | RESMED INC | S — Open-market sale [10b5-1] | 2.0K | $260.22 | $520K |
| 2026-02-06 | RMD | RESMED INC | S — Open-market sale [10b5-1] | 2.0K | $251.31 | $503K |
| 2026-01-09 | RMD | RESMED INC | S — Open-market sale [10b5-1] | 2.0K | $248.83 | $498K |
| 2025-07-02 | RMD | RESMED INC | S — Open-market sale | 945 | $255.49 | $241K |
| 2025-06-04 | RMD | RESMED INC | S — Open-market sale | 2.0K | $247.32 | $495K |
| 2025-05-07 | RMD | RESMED INC | S — Open-market sale | 2.0K | $242.25 | $484K |
| 2025-04-02 | RMD | RESMED INC | S — Open-market sale | 2.0K | $219.74 | $439K |
| 2024-12-05 | RMD | RESMED INC | S — Open-market sale [10b5-1] | 2.0K | $245.65 | $491K |
| 2024-11-22 | RMD | RESMED INC | A — Grant or award | 542 | $0.00 | |
| 2024-11-12 | RMD | RESMED INC | F — Tax withholding / forfeiture | 528 | $252.38 | $133K |
| 2024-11-08 | RMD | RESMED INC | S — Open-market sale [10b5-1] | 2.0K | $248.74 | $497K |
| 2024-10-02 | RMD | RESMED INC | S — Open-market sale [10b5-1] | 2.0K | $237.20 | $474K |
Peter C. Farrell is a prominent figure in the medical device industry, known for his role as a director at ResMed Inc., a leading company in respiratory care. He has also been involved with Arcturus Therapeutics Holdings Inc., contributing to advancements in therapeutic technologies.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 11 open-market sales ($5.09M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live FARRELL PETER C profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.